Direct and Indirect Costs of Diabetes in Brazil in 2016
References
- Abegunde DO, et al. The burden and costs of chronic diseases in low-income and middle-income countries. The Lancet. 2007; 370(9603): 1929–1938. DOI: 10.1016/S0140-6736(07)61696-1
- ANS. Beneficiarios de planos privados de saúde, por cobertura assistencial (Brasil – 2009–2019); 2019.
- A. D. Association, et al. Economic consequences of diabetes mellitus in the US in 1997. Diabetes Care. 1998; 21(2): 296–309. DOI: 10.2337/diacare.21.2.296
- A. D. Association, et al. Economic costs of diabetes in the US in 2012. Diabetes Care. 2013; 36(4): 1033–1046. DOI: 10.2337/dc12-2625
- A. D. Association, et al. Economic Costs of Diabetes in the US in 2017. Diabetes Care. 2018; 41(5): 917–928. DOI: 10.2337/dci18-0007
- Atlas D.
International Diabetes Federation . IDF Diabetes Atlas, 7th edn. Brussels, Belgium: International Diabetes Federation; 2015. - Bahia LR, et al. The costs of type 2 diabetes mellitus outpatient care in the Brazilian public health system. Value in Health. 2011; 14(5): S137–S140. DOI: 10.1016/j.jval.2011.05.009
- Barcelo A, et al. The cost of diabetes in Latin America and the Caribbean. Bulletin of the World Health Organization. 2003; 81(1): 19–27.
- Barcelo A, et al. The cost of diabetes in Latin America and the Caribbean in 2015: Evidence for decision and policy makers. Journal of Global Health. 2017; 7(2). DOI: 10.7189/jogh.07.020410
- Bloom DE, et al. The global economic burden of noncommunicable diseases. Tech. rep. Program on the Global Demography of Aging; 2012.
- Bommer C, et al. Global economic burden of diabetes in adults: Projections from 2015 to 2030. Diabetes Care. 2018; dc171962. DOI: 10.2337/dc17-1962
- Bommer C, et al. The global economic burden of diabetes in adults aged 20–79 years: A cost-of-illness study. The Lancet Diabetes & Endocrinology. 2017; 5(6): 423–430. DOI: 10.1016/S2213-8587(17)30097-9
- Borges NB, Ferraz MB, Chacra AR. The cost of type 2 diabetes in Brazil: Evaluation of a diabetes care center in the city of São Paulo, Brazil. Diabetology & Metabolic Syndrome. 2014; 6(1): 122. DOI: 10.1186/1758-5996-6-122
- Cobas RA, et al. The cost of type 1 diabetes: A nationwide multicentre study in Brazil. Bulletin of the World Health Organization. 2013; 91(6): 434–440. DOI: 10.2471/BLT.12.110387
- Codo AC, et al. Elevated glucose levels favor Sars-Cov-2 infection and monocyte response through a Hif-1α/Glycolysis Dependent Axis. Cell Metabolism – under review; 2020. DOI: 10.2139/ssrn.3606770
- Control D, CTR Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine. 1993; 329(14): 977–986. DOI: 10.1056/NEJM199309303291401
- Costa AF, et al. Burden of type 2 diabetes mellitus in Brazil. Cadernos de saude publica. 2017; 33(2).
- Coutinho WF, Júnior WSS. Diabetes care in Brazil. Annals of Global Health. 2015; 81(6): 735–741. DOI: 10.1016/j.aogh.2015.12.010
- Domeikiene A, et al. Direct cost of patients with type 2 diabetes mellitus healthcare and its complications in Lithuania. Medicina. 2014; 50(1): 54–60. DOI: 10.1016/j.medici.2014.05.007
- Duncan BB, et al. The burden of diabetes and hyperglycemia in Brazil-past and present: Findings from the Global Burden of Disease Study 2015. Diabetology & Metabolic Syndrome. 2017; 9(1): 18. DOI: 10.1186/s13098-017-0216-2
- Elrayah-Eliadarous HA, et al. Economic and social impact of diabetes mellitus in a low-income country: A case-control study in Sudan. Journal of Diabetes. 2017; 9(12): 1082–1090. DOI: 10.1111/1753-0407.12540
- I. I. B. de Geografia e Estatística. Pesquisa Nacional de Saúde 2013: percepção do estado de saúde, estilos de vida e doenças crônicas: Brasil, grandes regiões e unidades da federação; 2014.
- I. I. B. de Geografia e Estatistica. Pesquisa de Orcamentos Familiares 2008–2009 – POF. URL:
https://biblioteca.ibge.gov.br/visualizacao/livros/liv50063.pdf . - I. I. B. de Geografia e Estatistica. Projecões da Populacão. URL:
https://www.ibge.gov.br/estatisticas/sociais/populacao/9109-projecao-da-populacao.html?edicao=17996 . - Hussain A, Bhowmik B, do Vale Moreira NC. COVID-19 and diabetes: Knowledge in progress. Diabetes Research and Clinical Practice. 2020; 108142. DOI: 10.1016/j.diabres.2020.108142
- IBGE. Pesquisa Nacional de Saúde 2013: arquivos de microdadps; 2013.
- Kumar A, et al. Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis. Diabetes & Metabolic Syndrome: Clinical Research & Reviews; 2020. DOI: 10.1016/j.dsx.2020.04.044
- Li B, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clinical Research in Cardiology. 2020; 1–8. DOI: 10.1007/s00392-020-01626-9
- Li X, Xu Z, Weng J, et al. Direct medical costs of type 2 diabetes in China: A multicentre, prospective cohort study. In: The Lancet Diabetes & Endocrinology. 2016; 4: S5. DOI: 10.1016/S2213-8587(16)30360-6
- Malerbi DA, Franco LJ, et al. Multicenter study of the prevalence of diabetes mellitus and impaired glucose tolerance in the urban Brazilian population aged 30–69 yr. Diabetes Care. 1992; 15(11): 1509–1516. DOI: 10.2337/diacare.15.11.1509
- Mathauer I, Wittenbecher F, World Health Organization, et al. DRG-based payments systems in low-and middle-income countries: Implementation experiences and challenges. Tech. rep. World Health Organization; 2012.
- Mendis S, Chestnov O. Costs, benefits, and effectiveness of interventions for the prevention, treatment, and control of cardiovascular diseases and diabetes in Africa. Progress in Cardiovascular Diseases. 2013; 56(3): 314–321. DOI: 10.1016/j.pcad.2013.09.001
- Ogurtsova K, et al. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Research and Clinical Practice. 2017; 128: 40–50. DOI: 10.1016/j.diabres.2017.03.024
- World Health Organization, et al. Fact Sheet N 138. Geneva, Switzerland: WHO; 2002.
- World Health Organization, et al. Global report on diabetes. World Health Organization; 2016.
- Pierro Bd. Demandas crescentes. Revista Pesquisa Fapesp. 2017; 18–25.
- Quarti Machado Rosa M, et al. Disease and economic burden of hospitalizations attributable to diabetes mellitus and its complications: A nationwide study in Brazil. International Journal of Environmental Research and Public Health. 2018; 15(2): 294. DOI: 10.3390/ijerph15020294
- Rosa R, et al. Estimated hospitalizations attributable to Diabetes Mellitus within the public health-care system in Brazil from 2008 to 2010: Study DIAPS 79. Revista da Associação Médica Brasileira. 2014; 60(3): 222–230. DOI: 10.1590/1806-9282.60.03.010
- Rossaneis MA, et al. Diferenças entre mulheres e homens diabéticos no autocuidado com os pés e estilo de vida. Revista Latino-Americana de Enfermagem. 2016; 24: 1–8.
- da Saude M. Farmacia Popular – Sobre o programa. URL:
http://portalms.saude.gov.br/acoes-e-programas/farmacia-popular/sobre-o-programa . - Schmidt MI, et al. High prevalence of diabetes and intermediate hyperglycemia–the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Diabetology & Metabolic Syndrome. 2014; 6(1): 123. DOI: 10.1186/1758-5996-6-123
- Yu MK, et al. Sex disparities in diabetes process of care measures and self-care in high-risk patients. Journal of Diabetes Research; 2013. DOI: 10.1155/2013/575814
- Zhuo X, Zhang P, Hoerger TJ. Lifetime direct medical costs of treating type 2 diabetes and diabetic complications. American Journal of Preventive Medicine. 2013; 45(3): 253–261. DOI: 10.1016/j.amepre.2013.04.017
DOI: https://doi.org/10.5334/aogh.3000 | Journal eISSN: 2214-9996
Language: English
Published on: Mar 3, 2022
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
© 2022 Paula Pereda, Vanessa Boarati, Bruna Guidetti, Ana Clara Duran, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.